BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23521813)

  • 1. Breast cancer after kidney transplantation: a single institution review.
    Kwak HY; Chae BJ; Bae JS; Jung SS; Song BJ
    World J Surg Oncol; 2013 Mar; 11():77. PubMed ID: 23521813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and prognosis of breast cancer after liver or kidney transplantation.
    Jeong IJ; Lee SG; Kim YH; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2018 Jan; 167(1):101-106. PubMed ID: 28914398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplantation Malignancy After Kidney Transplantation in Turkey.
    Keles Y; Tekin S; Duzenli M; Yuksel Y; Yücetin L; Dosemeci L; Sengul A; Demirbaş A; Tuncer M
    Transplant Proc; 2015 Jun; 47(5):1418-20. PubMed ID: 26093732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis.
    Livingston-Rosanoff D; Foley DP; Leverson G; Wilke LG
    J Am Coll Surg; 2019 Dec; 229(6):568-579. PubMed ID: 31666186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan.
    Chiu HF; Chung MC; Chung CJ; Yu TM; Shu KH; Wu MJ
    Transplant Proc; 2016 Apr; 48(3):918-20. PubMed ID: 27234767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative cancer incidence and mortality after kidney transplantation in Japan: A long-term multicenter cohort study.
    Imamura R; Nakazawa S; Yamanaka K; Kakuta Y; Tsutahara K; Taniguchi A; Kawamura M; Kato T; Abe T; Uemura M; Takao T; Kishikawa H; Nonomura N
    Cancer Med; 2021 Apr; 10(7):2205-2215. PubMed ID: 33314709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
    Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center.
    Tan CS; Loh HL; Foo MW; Choong LH; Wong KS; Kee TY
    Clin Transplant; 2013; 27(4):E462-8. PubMed ID: 23682851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of kidney transplant in primary, repeat, and kidney-after-nonrenal solid-organ transplantation: 15-year analysis of recent UNOS database.
    El-Husseini A; Aghil A; Ramirez J; Sawaya B; Rajagopalan N; Baz M; Mei X; Davenport DL; Gedaly R
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28881060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental diagnosis of gastric cancer in transplant recipients improves patient survival.
    Buell JF; Husted T; Hanaway MJ; Peddi VR; Trofe J; Gross TG; Beebe TM; First MR; Woodle ES
    Surgery; 2002 Oct; 132(4):754-8; discussion 758-60. PubMed ID: 12407362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001.
    Kwong A; Mang OW; Wong CH; Chau WW; Law SC;
    Ann Surg Oncol; 2011 Oct; 18(11):3072-8. PubMed ID: 21847700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.
    Balabram D; Turra CM; Gobbi H
    BMC Cancer; 2013 Sep; 13():434. PubMed ID: 24063763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-Transplant Malignancy after Pediatric Kidney Transplantation: Retrospective Analysis of Incidence and Risk Factors in 884 Patients Receiving Transplants Between 1963 and 2015 at the University of Minnesota.
    Serrano OK; Bangdiwala AS; Vock DM; Chinnakotla S; Dunn TB; Finger EB; Kandaswamy R; Pruett TL; Najarian JS; Matas AJ; Chavers BM
    J Am Coll Surg; 2017 Aug; 225(2):181-193. PubMed ID: 28445794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
    Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo noncutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients.
    Cena T; Musetti C; Quaglia M; Magnani C; Stratta P; Bagnardi V; Cantaluppi V
    Transpl Int; 2016 Oct; 29(10):1085-93. PubMed ID: 27343849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UNOS Renal Transplant Registry: Review of the Last Decade.
    Andre M; Huang E; Everly M; Bunnapradist S
    Clin Transpl; 2014; ():1-12. PubMed ID: 26281122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience.
    Al-Ghareeb SM; El-Agroudy AE; Al Arrayed SM; Al Arrayed A; Alhellow HA
    Exp Clin Transplant; 2012 Oct; 10(5):458-65. PubMed ID: 22943190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients.
    Hulbert AL; Delahunty AJ; Rajab A; Forbes RC; Winters HA
    Clin Transplant; 2013; 27(4):E521-7. PubMed ID: 23923974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early immunosuppression treatment correlates with later de novo donor-specific antibody development after kidney and pancreas transplantation.
    Pelletier RP; Rajab AA; Diez A; DiPaola NR; Bumgardner GL; Elkhammas EA; Henry ML
    Clin Transplant; 2015 Dec; 29(12):1119-27. PubMed ID: 26382932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.